Hepatitis C prevalence in incarcerated settings between 2013–2021: a systematic review and meta-analysis | BMC Public Health & More Trending News

 

  • World Health Organization. Global Hepatitis Report, 2017. WHO: Geneva, April, 2017. http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf.

  • Bielen R, Stumo SR, Halford R, Werling Okay, Reic T, Stover H, Robaeys G, Lazarus JV. Harm discount and viral hepatitis C in European prisons: a cross-sectional survey of 25 nations. Harm Reduct J. 2018;15(1):25.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Stover H, Meroueh F, Marco A, Keppler Okay, Saiz de la Hoya P, Littlewood R, Wright N, Nava F, Alam F, Walcher S, et al. Offering HCV therapy to prisoners is a crucial alternative: key ideas based mostly on coverage and follow evaluation in Europe. BMC Public Health. 2019;19(1):30.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Wright N, Reimer J, Somaini L, Roncero C, Maremmani I, Simon N, Krajci P, Littlewood R, D’Agnone O, Alho H, et al. Are we able to deal with hepatitis C virus in people with opioid use dysfunction: evaluation of readiness in European nations on the idea of an expert-generated mannequin. Eur J Gastroenterol Hepatol. 2017;29(11):1206–14.

    PubMed 

    Google Scholar 

  • Roose RJ, Cockerham-Colas L, Soloway I, Batchelder A, Litwin AH. Reducing boundaries to hepatitis C therapy amongst drug customers: an built-in hepatitis C peer training and assist program. J Health Care Poor Underserved. 2014;25(2):652–62.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Dolan Okay, Wirtz AL, Moazen B, Ndeffo-Mbah M, Galvani A, Kinner SA, Courtney R, McKee M, Amon JJ, Maher L, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet (London, England). 2016;388(10049):1089–102.

    PubMed 

    Google Scholar 

  • Larney S, Kopinski H, Beckwith CG, Zaller ND, Jarlais DD, Hagan H, Rich JD, van den Bergh BJ, Degenhardt L. The incidence and prevalence of hepatitis C in prisons and different closed settings: outcomes of a systematic review and meta-analysis. Hepatology (Baltimore, MD). 2013;58(4):1215–24.

    PubMed 

    Google Scholar 

  • Mohd Hanafiah Okay, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus an infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology (Baltimore, MD). 2013;57(4):1333–42.

    PubMed 

    Google Scholar 

  • World Prison Population List (12 th version) [https://www.prisonstudies.org/sites/default/files/resources/downloads/wppl_12.pdf].

  • Arain A, Robaeys G, Stover H. Hepatitis C in European prisons: a name for an evidence-informed response. BMC Infect Dis. 2014;14(Suppl 6):S17.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Galea G, Enggist S, Udesen C, Møller L. Prisons and Health. In: World Health Organization. 2014. p. 165–70.

    Google Scholar 

  • ECDC. Surveillance and prevention of hepatitis B and C in Europe. Stockholm: European Centre for Disease Prevention and Control; 2010.

    Google Scholar 

  • Hagan LM, Schinazi RF. Best methods for world HCV eradication. Liver Int. 2013;33(Suppl 1):68–79.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Tsoulfas G, Goulis I, Giakoustidis D, Akriviadis E, Agorastou P, Imvrios G, Papanikolaou V. Hepatitis C and liver transplantation. Hippokratia. 2009;13(4):211–5.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Rich JD, Allen SA, Williams BA. Responding to hepatitis C by means of the felony justice system. N Engl J Med. 2014;370(20):1871–4.

    CAS 
    PubMed 

    Google Scholar 

  • Larney S, C GB, N DZ, B TM, Rich J. “Seek, test, treat and retain” for hepatitis C in the United States felony justice system. Int J Prison Health 2014;10(3):164-171.

  • Olafsson S, Fridriksdottir RH, Love TJ, Tyrfingsson T, Runarsdottir V, Hansdottir I, Bergmann OM, Björnsson ES, Johannsson B, Sigurdardottir B, et al. Cascade of care in the course of the first 36 months of the therapy as prevention for hepatitis C (TraP HepC) programme in Iceland: a population-based examine. Lancet Gastroenterol Hepatol. 2021;6(8):628–37.

    PubMed 

    Google Scholar 

  • Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 assertion: an up to date guideline for reporting systematic evaluations. Rev Esp Cardiol (Engl Ed). 2021;74(9):790–9.

    PubMed 

    Google Scholar 

  • Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L. Global epidemiology of hepatitis B and hepatitis C in individuals who inject medication: outcomes of systematic evaluations. Lancet (London, England). 2011;378(9791):571–83.

    PubMed 

    Google Scholar 

  • R: A language and setting for statistical computing [https://www.R-project.org].

  • Schwarzer G, Chemaitelly H, Abu-Raddad LJ, Rucker G. Seriously deceptive outcomes utilizing inverse of Freeman-Tukey double arcsine transformation in meta-analysis of single proportions. Res Synth Methods. 2019;10(3):476–83.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Borenstein M, Hedges L, Higgings J, Rothstein H: Introduction to Meta-analysis. In. Edited by Ltd JWS. UK; 2009.

  • Azbel L, Wickersham JA, Wegman MP, Polonsky M, Suleymanov M, Ismayilov R, Dvoryak S, Rotberga S, Altice FL. Burden of substance use problems, psychological sickness, and correlates of infectious illnesses amongst soon-to-be launched prisoners in Azerbaijan. Drug Alcohol Depend. 2015;151:68–75.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Hodzic H, Bajramovic A, Obradovic Z, Mahmic-Kaknjo M. Intravenous medication abuse as the primary danger issue of accelerating hepatitis C an infection prevalence in prisoners in Zenica, Bosnia and Herzegovina. Med Glas (Zenica). 2017;14(1):73–8.

    PubMed 

    Google Scholar 

  • Kivimets Okay, Uusküla A, Lazarus JV, Ott Okay. Hepatitis C seropositivity amongst newly incarcerated prisoners in Estonia: information evaluation of digital well being data from 2014 to 2015. BMC Infect Dis. 2018;18:339.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Bergen-Cico D, Sikharulidze Okay, Ivanashvili N, Ivanishvili M, Keshelava T. Hepatitis C Risk and Protective Factors Associated With Drug Policies in the Republic of Georgia. World Med Health Policy. 2017;9(1):45–64.

    Google Scholar 

  • Harris AM, Chokoshvili O, Biddle J, Turashvili Okay, Japaridze M, Burjanadze I, Tsertsvadze T, Sharvadze L, Karchava M, Talakvadze A, et al. An analysis of the hepatitis C testing, care and therapy program in the nation of Georgia’s corrections system, December 2013 – April 2015. BMC Public Health. 2019;19(Suppl 3):466.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Vanya M, Szili Okay, Magori Okay, Krisztina V. Skin illnesses and sexually transmitted an infection in a Hungarian jail. Med Microbiol. 2017;28:95–6.

    Google Scholar 

  • Jovanovska T, Kocic B, Stojcevska VP. Prevalence, attitudes and data about HIV HBV and HCV infections amongst inmates in prisons Prilep and Bitola–a pilot examine. Coll Antropol. 2014;38(2):417–22.

    PubMed 

    Google Scholar 

  • Keten D, Emin Ova M, Sirri Keten H, Keten A, Gulderen E, Tumer S, Caliskan A, Kulotu S. The Prevalence of Hepatitis B and C Among Prisoners in Kahramanmaras, Turkey. Jundishapur J Microbiol. 2016;9(2):e31598.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Kose S, Adar P, Gozaydin A, Kuzucu L, Akkoclu G. Hepatitis B and Hepatitis C in prisons: a prevalence examine. Int J Prison Health. 2019;15(2):162–7.

    PubMed 

    Google Scholar 

  • Azbel L, Wickersham JA, Grishaev Y, Dvoryak S, Altice FL. Burden of infectious illnesses, substance use problems, and psychological sickness amongst Ukrainian prisoners transitioning to the neighborhood. PLoS One. 2013;8(3):e59643.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Silbernagl M, Slamanig R, Fischer G, Brandt L. Hepatitis C an infection and psychiatric burden in two imprisoned cohorts: Young offenders and opioid-maintained prisoners. Health Policy. 2018;122(12):1392–402.

    PubMed 

    Google Scholar 

  • Busschots D, Kremer C, Bielen R, Koc OM, Heyens L, Brixko C, Laukens P, Orlent H, Bilaey P, De Smet F, et al. A multicentre interventional examine to evaluate blood-borne viral infections in Belgian prisons. BMC Infect Dis. 2021;21(1):708.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Soholm J, Holm DK, Mossner B, Madsen LW, Hansen JF, Weis N, Sauer AP, Awad T, Christensen PB. Incidence, prevalence and danger elements for hepatitis C in Danish prisons. PLoS One. 2019;14(7):e0220297.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Semaille C, Le Strat Y, Chiron E, Chemlal Okay, Valantin MA, Serre P, Cate L, Barbier C, Jauffret-Roustide M. Prevalence of human immunodeficiency virus and hepatitis C virus amongst French jail inmates in 2010: a problem for public well being coverage. Euro Surveill. 2013;18(28):20524.

    PubMed 

    Google Scholar 

  • Roux P, Sagaon-Teyssier L, Lions C, Fugon L, Verger P, Carrieri MP. HCV seropositivity in inmates and in the final inhabitants: an averaging method to determine precedence prevention interventions. BMJ Open. 2014;4(10):e005694.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Jacomet C, Guyot-Lénat A, Bonny C, Henquell C, Rude M, Dydymski S, Lesturgeon J-A, Lambert C, Pereira B, Schmidt J. Addressing the challenges of persistent viral infections and dependancy in prisons: the PRODEPIST examine. Euro J Public Health. 2016;26(1):122–8.

    Google Scholar 

  • Izquierdo L, Mellon G, Buchaillet C, Fac C, Soutiere MP, Pallier C, Dulioust A, Roque-Afonso AM. Prevalence of hepatitis E virus and reassessment of HIV and different hepatitis virus seroprevalences amongst French jail inmates. PLoS One. 2019;14(6):e0218482.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Crowley D, Lambert JS, Betts-Symonds G, Cullen W, Keevans M, Kelly E, Laird E, McHugh T, McKiernan S, Miggin SJ, et al. The seroprevalence of untreated persistent hepatitis C virus (HCV) an infection and related danger elements in male Irish prisoners: a cross-sectional examine, 2017. Euro Surveill. 2019;24(14):1800369.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Brandolini M, Novati S, De Silvestri A, Tinelli C, Patruno SF, Ranieri R, Seminari E. Prevalence and epidemiological correlates and therapy end result of HCV an infection in an Italian jail setting. BMC Public Health. 2013;13:981.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Foschi A, Casana M, Radice A, Ranieri R, d’Arminio Monforte A. Hepatitis C administration in prisons: an perception into each day medical follow in three main Italian correctional homes. Hepatology (Baltimore, MD). 2016;64(5):1821–2.

    PubMed 

    Google Scholar 

  • Masarone M, Caruso R, Aglitti A, Izzo C, De Matteis G, Attianese M, Pagano A, Persico M. Hepatitis C virus in jail: Difficult-to-reach, not to-treat. Results of a point-of-care screening and therapy program. Digest Liver Dis. 2020;52:541–6.

    CAS 

    Google Scholar 

  • Fiore V, De Matteis G, Ranieri R, Saderi L, Pontali E, Muredda A, Ialungo AM, Caruso R, Madeddu G, Sotgiu G, et al. HCV testing and therapy initiation in an Italian jail setting: a step-by-step mannequin to micro-eliminate hepatitis C. Int J Drug Policy. 2021;90:103055.

    PubMed 

    Google Scholar 

  • Marco A, Gallego C, Caylà J. Incidence of Hepatitis C Infection amongst Prisoners by Routine Laboratory Values throughout a 20-Year Period. PloS One. 2014;9(2):e90560.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Cuadrado A, Llerena S, Cobo C, Pallas JR, Mateo M, Cabezas J, Fortea JI, Alvarez S, Pellon R, Crespo J, et al. Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm. Am J Gastroenterol. 2018;113(11):1639–48.

    PubMed 

    Google Scholar 

  • Jiménez Galán G, Alia Alia C, Vegue González M, García Berriguete RM, Fernández González F, Fernández Rodríguez CM, González Fernández M, Gutiérrez García ML, Losa JE, Velasco M, et al. The contribution of telemedicine to hepatitis C elimination in a correctional facility. Rev Esp Enferm Dig. 2019;111(7):550–5.

    PubMed 

    Google Scholar 

  • Cabezas J, Llerena S, Mateo M, Alvarez R, Cobo C, Gonzalez V, Martro E, Cuadrado A, Crespo J. Hepatitis C Micro-Elimination past Prison Walls: Navigator-Assisted Test-and-Treat Strategy for Subjects Serving Non-Custodial Sentences. Diagnostics (Basel). 2021;11(5):877.

    PubMed 

    Google Scholar 

  • Taylor A, Munro A, Allen E, Dunleavy Okay, Cameron S, Miller L, Hickman M. Low incidence of hepatitis C virus amongst prisoners in Scotland. Addiction (Abingdon, England). 2013;108(7):1296–304.

    PubMed 

    Google Scholar 

  • Aisyah DN, Shallcross L, Hayward A, Aldridge RW, Hemming S, Yates S, Ferenando G, Possas L, Garber E, Watson JM, et al. Hepatitis C amongst susceptible populations: a seroprevalence examine of homeless, individuals who inject medication and prisoners in London. J Viral Hepat. 2018;25(11):1260–9.

    CAS 
    PubMed 

    Google Scholar 

  • Morey S, Hamoodi A, Jones D, Young T, Thompson C, Dhuny J, Buchanan E, Miller C, Hewett M, Valappil M, et al. Increased prognosis and therapy of hepatitis C in jail by common provide of testing and use of telemedicine. J Viral Hepat. 2019;26(1):101–8.

    PubMed 

    Google Scholar 

  • Perrett SE, Waite TD. Exploring HIV an infection in a UK susceptible prisoner inhabitants in response to newly recognized instances. Int J Prison Health. 2019;15(3):244–9.

    PubMed 

    Google Scholar 

  • Bhandari R, Morey S, Hamoodi A, Thompson C, Jones D, Hewett M, Hunter E, Taha Y, McPherson S. High price of hepatitis C reinfection following antiviral therapy in the North East England Prisons. J Viral Hepat. 2020;27(4):449–52.

    PubMed 

    Google Scholar 

  • Mohamed Z, Al-Kurdi D, Nelson M, Shimakawa Y, Selvapatt N, Lacey J, Thursz MR, Lemoine M, Brown AS. Time issues: Point of care screening and streamlined linkage to care dramatically improves hepatitis C therapy uptake in prisoners in England. Int J Drug Policy. 2020;75:102608.

    PubMed 

    Google Scholar 

  • Perrett SE, Plimmer A, Shankar AG, Craine N. Prevalence of HCV in prisons in Wales, UK and the affect of shifting to opt-out HCV testing. J Public Health (Oxf). 2020;42(2):423–8.

    PubMed 

    Google Scholar 

  • Gahrton C, Westman G, Lindahl Okay, Öhrn F, Dalgard O, Lidman C, Nilsson LH, Said Okay, Duberg AS, Aleman S. Prevalence of Viremic hepatitis C, hepatitis B, and HIV an infection, and vaccination standing amongst prisoners in Stockholm County. BMC Infect Dis. 2019;19(1):955.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Chacowry Pala Okay, Baggio S, Tran NT, Girardin F, Wolff H, Getaz L. Blood-borne and sexually transmitted infections: a cross-sectional examine in a Swiss jail. BMC Infect Dis. 2018;18(1):539.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Courtemanche Y, Poulin C, Serhir B, Alary M. HIV and hepatitis C virus infections in Quebec’s provincial detention centres: evaluating prevalence and associated dangerous behaviours between 2003 and 2014–2015. Can J Public Health. 2018;109(3):353–61.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Alvarez KJ, Befus M, Herzig CT, Larson E. Prevalence and correlates of hepatitis C virus an infection amongst inmates at two New York State correctional amenities. J Infect Public Health. 2014;7(6):517–21.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Cocoros N, Nettle E, Church D, Bourassa L, Sherwin V, Cranston Okay, Carr R, Fukuda HD, DeMaria A Jr. Screening for Hepatitis C as a Prevention Enhancement (SHAPE) for HIV: an integration pilot initiative in a Massachusetts County correctional facility. Public Health Rep. 2014;129(Suppl 1):5–11.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Wenger PJ, Rottnek F, Parker T, Crippin JS. Assessment of hepatitis C danger elements and an infection prevalence in a jail inhabitants. Am J Public Health. 2014;104(9):1722–7.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Kuncio DE, Newbern EC, Fernandez-Vina MH, Herdman B, Johnson CC, Viner KM. Comparison of risk-based hepatitis C screening and the true seroprevalence in an city jail system. J Urban Health. 2015;92(2):379–86.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Beckwith CG, Kurth AE, Bazerman LB, Patry EJ, Cates A, Tran L, Noska A, Kuo I. A pilot examine of fast hepatitis C virus testing in the Rhode Island Department of Corrections. J Public Health (Oxf). 2016;38(1):130–7.

    PubMed 

    Google Scholar 

  • Mahowald MK, Larney S, Zaller ND, Scharff N, Taylor LE, Beckwith CG, Noska A, Rich JD, Flanigan TP. Characterizing the Burden of Hepatitis C Infection Among Entrants to Pennsylvania State Prisons, 2004 to 2012. J Correct Health Care. 2016;22(1):41–5.

    PubMed 

    Google Scholar 

  • Schoenbachler BT, Smith BD, Sena AC, Hilton A, Bachman S, Lunda M, Spaulding AC. Hepatitis C Virus Testing and Linkage to Care in North Carolina and South Carolina Jails, 2012–2014. Public Health Rep. 2016;131(Suppl 2):98–104.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Stockman LJ, Greer J, Holzmacher R, Dittmann B, Hoftiezer SA, Alsum LE, Prieve A, Westergaard RP, Guilfoyle SM, Vergeront JM. Performance of Risk-Based and Birth-Cohort Strategies for Identifying Hepatitis C Virus Infection Among People Entering Prison, Wisconsin, 2014. Public Health Rep. 2016;131(4):544–51.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Akiyama MJ, Kaba F, Rosner Z, Alper H, Kopolow A, Litwin AH, Venters H, MacDonald R. Correlates of Hepatitis C Virus Infection in the Targeted Testing Program of the New York City Jail System. Public Health Rep. 2017;132(1):41–7.

    PubMed 

    Google Scholar 

  • de la Flor C, Porsa E, Nijhawan AE. Opt-out HIV and Hepatitis C Testing on the Dallas County Jail: Uptake, Prevalence, and Demographic Characteristics of Testers. Public Health Rep. 2017;132(6):617–21.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Hochstatter KR, Stockman LJ, Holzmacher R, Greer J, Seal DW, Taylor QA, Gill EK, Westergaard RP. The continuum of hepatitis C take care of felony justice concerned adults in the DAA period: a retrospective cohort examine demonstrating restricted therapy uptake and inconsistent linkage to community-based care. Health Justice. 2017;5(1):10.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Assoumou SA, Wang J, Tasillo A, Eftekhari Yazdi G, Tsui JI, Strick L, Linas BP. Hepatitis C Testing and Patient Characteristics in Washington State’s Prisons Between 2012 and 2016. Am J Prev Med. 2019;56(1):8–16.

    PubMed 

    Google Scholar 

  • Abe CM, Aguwa M, Zhao M, Sullivan J, Porsa E, Nijhawan AE. Hepatitis C Virus Infection in the Dallas County Jail: Implications for Screening, Prevention, and Linkage to Care. Public Health Rep. 2019;134(6):626–33.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Chan J, Kaba F, Schwartz J, Bocour A, Akiyama MJ, Rosner Z, Winters A, Yang P, MacDonald R. The hepatitis C virus care cascade in the New York City jail system in the course of the direct appearing antiviral therapy period, 2014–2017. EClinicalMedicine. 2020;27:100567.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Qureshi N, Tadesse M, Tran N, Henderson S: Establishing an Epidemiologic Profile of Hepatitis C Virus Infection on the Los Angeles County Jail. Public Health Rep 2021.https://doi.org/10.1177/33354920988610.

  • Adaszko D, Sotelo J, Orlando M, Adaszko A, Angeleri P. HIV, hepatitis B en C, syphilis and Tuberculosis prevalence in individuals disadvantaged of liberty for felony causes in Argentina. Final outcomes of a nationwide examine. Int J Infect Dis. 2018;73:202.

    Google Scholar 

  • Mendizabal M, Testa P, Rojas M, Colaci CS, Elías S, Nicolini P, Olguín S, Dunn C, Ronchi C, Barreiro M, et al. Pilot examine utilizing the ECHO mannequin to boost linkage to take care of sufferers with hepatitis C in the custodial setting. J Viral Hepat. 2020;27(12):1430–6.

    PubMed 

    Google Scholar 

  • Barros LA, Pessoni GC, Teles SA, Souza SM, Matos MA, Martins RM, Del-Rios NH, Carneiro MA. Epidemiology of the viral hepatitis B and C in feminine prisoners of Metropolitan Regional Prison Complex in the State of Goias, Central Brazil. Rev Soc Bras Med Trop. 2013;46(1):24–9.

    PubMed 

    Google Scholar 

  • Falquetto TC, Endringer DC, de Andrade TU, Lenz D. Hepatitis C in prisoners and non-prisoners in Colatina, Espírito Santo. Brazil Braz J Pharm Sci. 2013;49(4):737–44.

    Google Scholar 

  • El Maerrawi I, Carvalho HB. Prevalence and danger elements related to HIV an infection, hepatitis and syphilis in a state jail of Sao Paulo. Int J STD AIDS. 2015;26(2):120–7.

    PubMed 

    Google Scholar 

  • Puga MA, Bandeira LM, Pompilio MA, Croda J, Rezende GR, Dorisbor LF, Tanaka TS, Cesar GA, Teles SA, Simionatto S, et al. Prevalence and Incidence of HCV Infection amongst Prisoners in Central Brazil. PLoS One. 2017;12(1):e0169195.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Felisberto M, Saretto AA, Wopereis S, Machado MJ, Spada C. Prevalence of HCV an infection in a jail inhabitants of the better Florianopolis space. Rev Soc Bras Med Trop. 2019;52:e20190143.

    PubMed 

    Google Scholar 

  • Machado F, Becker D, Fernando de Oliveira C, Possuelo L, Pollo Renner J. Seroprevalence of HIV, hepatitis B and C and syphilis an infection in prisoners of the central area of Rio Grande do Sul. Brazil Mundo da Saude. 2019;43(1):117–28.

    Google Scholar 

  • do Nascimento CT, Pena DZ, Giuffrida R, Bandeira Monteiro FN, da Silva FA, Flores EF, Prestes-Carneiro LE. Prevalence and epidemiological traits of inmates identified with infectious illnesses dwelling in a area with a excessive variety of prisons in São Paulo state, Brazil. BMJ Open. 2020;10(9):e037045.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Bautista-Arredondo S, Gonzalez A, Servan-Mori E, Beynon F, Juarez-Figueroa L, Conde-Glez CJ, Gras N, Sierra-Madero J, Lopez-Ridaura R, Volkow P, et al. A Cross-Sectional Study of Prisoners in Mexico City Comparing Prevalence of Transmissible Infections and Chronic Diseases with That in the General Population. PLoS One. 2015;10(7):e0131718.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Belaunzaran-Zamudio PF, Mosqueda-Gomez JL, Macias-Hernandez A, Rodriguez-Ramirez S, Sierra-Madero J, Beyrer C. Burden of HIV, Syphilis, and Hepatitis B and C Among Inmates in a Prison State System in Mexico. AIDS Res Hum Retroviruses. 2017;33(6):524–33.

    PubMed 

    Google Scholar 

  • Silverman-Retana O, Servan-Mori E, McCoy SI, Larney S, Bautista-Arredondo S. Hepatitis C antibody prevalence amongst Mexico City prisoners injecting authorized and unlawful substances. Drug Alcohol Depend. 2017;181:140–5.

    PubMed 

    Google Scholar 

  • Azbel L, Polonsky M, Wegman M, Shumskaya N, Kurmanalieva A, Asanov A, Wickersham JA, Dvoriak S, Altice FL. Intersecting epidemics of HIV, HCV, and syphilis amongst soon-to-be launched prisoners in Kyrgyzstan: Implications for prevention and therapy. Int J Drug Policy. 2016;37:9–20.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Yang TH, Fang YJ, Hsu SJ, Lee JY, Chiu MC, Yu JJ, Kuo CC, Chen CH. Microelimination of Chronic Hepatitis C by Universal Screening Plus Direct-Acting Antivirals for Incarcerated Persons in Taiwan. Open Forum Infect Dis. 2020;7(8):ofaa301.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Ramamoorthy M, Venketeswaran A, Seenivasan P, Revathy M, Manimaran M, Chitra S, Malavizhi M, Frederick T. Risk elements and prevalence, hepatitis B virus and hepatitis C virus amongst jail inmates, Chennai, India, 2015. Int J Infect Dis. 2016;53:90.

    Google Scholar 

  • Tyagi SK, Sovani V, Dias NP, Tyagi D, Saxena S. Prevalence and danger elements of HCV an infection in a jail setting in Uttar Pradesh, India. Indian J Public Health Res Dev. 2018;9(9):346–52.

    Google Scholar 

  • Prasetyo AA, Dirgahayu P, Sari Y, Hudiyono H, Kageyama S. Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia. J Infect Dev Ctries. 2013;7(6):453–67.

    PubMed 

    Google Scholar 

  • Pervaiz A, Sipra FS, Rana TH, Qadeer I. PRE-DONATION SCREENING OF VOLUNTEER PRISONER BLOOD DONORS FOR HEPATITIS B AND C IN PRISONS OF PUNJAB, PAKISTAN. J Ayub Med Coll Abbottabad. 2015;27(4):794–7.

    PubMed 

    Google Scholar 

  • Wali A, Khan D, Safdar N, Shawani Z, Fatima R, Yaqoob A, Qadir A, Ahmed S, Rashid H, Ahmed B, et al. Prevalence of tuberculosis, HIV/AIDS, and hepatitis; in a jail of Balochistan: a cross-sectional survey. BMC Public Health. 2019;19(1):1631.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Niriella MA, Hapangama A, Luke HP, Pathmeswaran A, Kuruppuarachchi KA, de Silva HJ. Prevalence of hepatitis B and hepatitis C infections and their relationship to injectable drug use in a cohort of Sri Lankan jail inmates. Ceylon Med J. 2015;60(1):18–20.

    CAS 
    PubMed 

    Google Scholar 

  • Salem F, Hekmat S, Aghasadeghi M, Javadi F, Gholamz H, Mostafavi E. Prevalence and danger elements of hepatitis B virus genotype d amongst inmates in alborz province, Iran: a cross-sectional survey. Jundishapur J Microbiol 2013;6(6):e10221

  • Ziaee M, Sharifzadeh G, Namaee MH, Fereidouni M. Prevalence of HIV and Hepatitis B, C, D Infections and Their Associated Risk Factors amongst Prisoners in Southern Khorasan Province, Iran. Iran J Public Health. 2014;43(2):229–34.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Khajedaluee M, Babaei A, Vakili R, Valizade N, Homaei Shandiz F, Alavian SM, Seyed Nozadi M, Jazayeri SM, Hassannia T. Sero-Prevalence of Bloodborne Tumor Viruses (HCV, HBV, HTLV-I and KSHV Infections) and Related Risk Factors amongst Prisoners in Razavi Khorasan Province, Iran, in 2008. Hepat Mon. 2016;16(12):e31541.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Moradi G, Gouya MM, Azimizan Zavareh F, Mohamadi Bolbanabad A, Darvishi S, Aghasadeghi MR, Nabavi M, Alasvand R, Tashakorian M, Nouri B, et al. Prevalence and danger elements for HBV and HCV in prisoners in Iran: a nationwide bio-behavioural surveillance survey in 2015. Trop Med Int Health. 2018;23(6):641–9.

    CAS 
    PubMed 

    Google Scholar 

  • Ghafari S, Sharifzadeh G, Jamali S, Taji B, Javadmoosavi SY, Ziaee M. Prevalence of Hepatitis B and C amongst Drug-Abusing Male Prisoners in Birjand, South Khorasan, Iran. Arch Iran Med. 2019;22(9):501–4.

    PubMed 

    Google Scholar 

  • Khademi N, Skakiba E, Khodadoust M, Khoramdad M. Seroprevalence and Related Risk Behaviors of Hepatitis C, Hepatitis B and HIV Infections amongst Male Prisoners in Kermanshah, Iran. Arch Iran Med. 2019;22(10):588–91.

    PubMed 

    Google Scholar 

  • Moradi G, Jafari S, Zarei B, Mahboobi M, Azimian Zavareh F, Molaeipoor L, Mohamadi Bolbanabad A, Darvishi S, Aghasadeghi MR, Tashakorian M, et al. Prevalence and Risk Factors for Hepatitis B and Hepatitis C Exposure in Iranian Prisoners: A National Study in 2016. Hepat Mon. 2019;19(7):e91129.

    Google Scholar 

  • Sharafi H, Poustchi H, Azimian F, Tamadoni B, Ramezani R, Gouya MM, Sheikh M, Hashemi F, Tashakorian M, Alasvand R, et al. Performance of a fast diagnostic take a look at for screening of hepatitis C in a real-life jail setting. J Clin Virol. 2019;113:20–3.

    PubMed 

    Google Scholar 

  • Hariri S, Sharafi H, Sheikh M, Merat S, Hashemi F, Azimian F, Tamadoni B, Ramazani R, Gouya MM, Abbasi B, et al. Continuum of hepatitis C care cascade in jail and following launch in the direct-acting antivirals period. Harm Reduct J. 2020;17(1):80.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Hariri S, Sharafkhah M, Alavi M, Roshandel G, Fazel A, Amiriani T, Motamed-Gorji N, Bazazan A, Merat S, Poustchi H, et al. A easy risk-based technique for hepatitis C virus screening amongst incarcerated individuals in a low- to middle-income setting. Harm Reduct J. 2020;17(1):56.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Reekie JM, Levy MH, Richards AH, Wake CJ, Siddall DA, Beasley HM, Kumar S, Butler TG. Trends in HIV, hepatitis B and hepatitis C prevalence amongst Australian prisoners – 2004, 2007, 2010. Med J Aust. 2014;200(5):277–80.

    PubMed 

    Google Scholar 

  • Cunningham EB, Hajarizadeh B, Bretana NA, Amin J, Betz-Stablein B, Dore GJ, Luciani F, Teutsch S, Dolan Okay, Lloyd AR, et al. Ongoing incident hepatitis C virus an infection amongst individuals with a historical past of injecting drug use in an Australian jail setting, 2005–2014: The HITS-p examine. J Viral Hepat. 2017;24(9):733–41.

    CAS 
    PubMed 

    Google Scholar 

  • Snow KJ, Richards AH, Kinner SA. Use of a number of information sources to estimate hepatitis C seroprevalence amongst prisoners: a retrospective cohort examine. PLoS One. 2017;12(7):e0180646.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Hajarizadeh B, Grebely J, Byrne M, Marks P, Amin J, McManus H, Butler T, Cunningham EB, Vickerman P, Martin NK, et al. Evaluation of hepatitis C treatment-as-prevention inside Australian prisons (SToP-C): a potential cohort examine. Lancet Gastroenterol Hepatol. 2021;6(7):533–46.

    PubMed 

    Google Scholar 

  • Sullivan RP, Baird R, Freeman Okay, Heggie H, Davis JS, Marshall CS, Davies J. Viral hepatitis in correctional amenities in the Northern Territory of Australia 2003–2017. BMC Infect Dis. 2021;21(1):584.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Jaquet A, Wandeler G, Tine J, Dagnra CA, Attia A, Patassi A, Ndiaye A, de Ledinghen V, Ekouevi DK, Seydi M, et al. HIV an infection, viral hepatitis and liver fibrosis amongst jail inmates in West Africa. BMC Infect Dis. 2016;16:249.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Okafor IM, Ugwu SO, Okoroiwu HU. Hepatitis C virus an infection and its related elements amongst prisoners in a Nigerian jail. BMC Gastroenterol. 2020;20(1):360.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Wakjira Okay, Abdissa A, Seid Y, Mekonnen Z. Seroprevalence and danger elements of hepatitis B, hepatitis C and HIV infections amongst prisoners in Jimma Town, Southwest Ethiopia. Asia Pac J Trop Dis. 2017;7(5):270–5.

    Google Scholar 

  • Kassa Y, Million Y, Biset S, Moges F. Hepatitis B and Hepatitis C Viral Infections and Associated Factors Among Prisoners in Northeast Ethiopia. J Blood Med. 2021;12:561–70.

    PubMed 
    PubMed Central 

    Google Scholar 

  • Mohamed HI, Saad ZM, Abd-Elreheem EM, Abd-ElGhany WM, Mohamed MS, Abd Elnaeem EA, Seedhom AE. Hepatitis C, hepatitis B and HIV an infection amongst Egyptian prisoners: seroprevalence, danger elements and associated persistent liver illnesses. J Infect Public Health. 2013;6(3):186–95.

    PubMed 

    Google Scholar 

  • WHO: Progress report on entry to hepatitis C therapy: Focus on overcoming boundaries in low- and middle-income nations. In. Edited by Organization WH. Geneva, Switzerland; 2018.

  • Robaeys G, Bielen R, Azar DG, Razavi H, Nevens F. Global genotype distribution of hepatitis C viral an infection amongst individuals who inject medication. J Hepatol. 2016;65(6):1094–103.

    PubMed 

    Google Scholar 

  • Ocal S, Muir AJ. Addressing Hepatitis C in the American Incarcerated Population: Strategies for Nationwide Elimination. Curr HIV/AIDS Rep. 2020;17(1):18–25.

    PubMed 

    Google Scholar 

  • Gower E, Estes C, Blach S, Razavi-Shearer Okay, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus an infection. J Hepatol. 2014;61(1 Suppl):S45-57.

    PubMed 

    Google Scholar 

  • Hepatitis C prevalence in incarcerated settings between 2013–2021: a systematic review and meta-analysis | BMC Public Health

    I’ve made it my mission to maintain you recent on all the most recent happenings in the world as of proper now, in the 12 months 2022, by way of this web site, and I’m sure that you will discover this to be an satisfying expertise. Regardless of what the newest information might must say, it stays a matter of intense curiosity.

    It has all the time been our purpose to speak with you and give you up-to-date information and details about the information without spending a dime. information about electrical energy, levels, donations, Bitcoin buying and selling, actual property, video video games, shopper tendencies, digital advertising and marketing, telecommunications, banking, journey, well being, cryptocurrency, and claims are all included right here. You preserve seeing our messages as a result of we labored arduous to take action. Due to the big variety of content material sorts, please don’t hesitate to

    Hepatitis C prevalence in incarcerated settings between 2013–2021: a systematic review and meta-analysis | BMC Public Health

    I’m sure you will discover the information I’ve ready and despatched out to be attention-grabbing and helpful; going ahead, we wish to embody recent options tailor-made to your pursuits each week.

    info with out going by means of us first, so we will present you the most recent and best information with out costing you a dime. The two of it’s possible you’ll be taught the specifics of the information collectively, providing you with a leg up. We’ll get to the subsequent step when a little time has gone.

    Our purpose is to maintain you recent on all the latest information from across the globe by posting related articles on our web site, so that you could be all the time be one step forward. In this way, you will by no means fall behind the most recent developments in that information.

    Hepatitis C prevalence in incarcerated settings between 2013–2021: a systematic review and meta-analysis | BMC Public Health

    The information tales I’ve shared with you might be both utterly authentic or will probably be utterly authentic to you and your viewers. Moreover, I’ve made all of this information accessible to every and each one in every of you, together with Trending News, Breaking News, Health News, Science News, Sports News, Entertainment News, Technology News, Business News, and World News, so that you could be all the time be in the know, all the time be one step forward of the scenario, and all the time get right this moment’s information. The path that’s two steps forward of the present one ought to all the time be taken.

    Read Entire Article🡽

    Scroll to Top